Showing 1 to 12 of 120 results
FDA Approves Twice-Yearly Injectable HIV Prevention Treatment
The FDA approved Yeztugo, Gilead's new twice-yearly injectable HIV prevention treatment, on June 18, 2025, showing over 99.9% efficacy in clinical trials involving over 4,000 participants across diverse populations, but concerns remain about its high potential cost.
FDA Approves Twice-Yearly Injectable HIV Prevention Treatment
The FDA approved Yeztugo, Gilead's new twice-yearly injectable HIV prevention treatment, on June 18, 2025, showing over 99.9% efficacy in clinical trials involving over 4,000 participants across diverse populations, but concerns remain about its high potential cost.
Progress
52% Bias Score
NHS Staff Shortages Cause Critical Delays in UK Cancer Care
Due to a shortage of radiologists and oncologists in the UK's NHS, cancer patients face significant delays in diagnosis and treatment, leading to cancer progression and increased mortality risk, as reported by the Royal College of Radiologists (RCR).
NHS Staff Shortages Cause Critical Delays in UK Cancer Care
Due to a shortage of radiologists and oncologists in the UK's NHS, cancer patients face significant delays in diagnosis and treatment, leading to cancer progression and increased mortality risk, as reported by the Royal College of Radiologists (RCR).
Progress
40% Bias Score
Exercise Significantly Reduces Cancer Death and Recurrence Risk
A clinical trial involving 889 colon cancer patients found that a structured exercise program after treatment reduced death risk by 37% and cancer recurrence by 28% compared to a control group, presenting evidence that exercise is as effective as, or better than, some cancer drugs.
Exercise Significantly Reduces Cancer Death and Recurrence Risk
A clinical trial involving 889 colon cancer patients found that a structured exercise program after treatment reduced death risk by 37% and cancer recurrence by 28% compared to a control group, presenting evidence that exercise is as effective as, or better than, some cancer drugs.
Progress
36% Bias Score
FDA Approves First Blood Test for Alzheimer's
The FDA approved a new blood test for Alzheimer's disease, increasing diagnostic accuracy to over 90% and improving access to treatment, particularly for those in underserved areas.
FDA Approves First Blood Test for Alzheimer's
The FDA approved a new blood test for Alzheimer's disease, increasing diagnostic accuracy to over 90% and improving access to treatment, particularly for those in underserved areas.
Progress
44% Bias Score
Prostate Cancer: Risk Factors, Early Detection Crucial
Prostate cancer, a common disease in men, is often diagnosed late, as exemplified by former US President Biden's recent advanced-stage diagnosis; risk factors include age, ethnicity, and family history, with rates sharply rising after age 50.
Prostate Cancer: Risk Factors, Early Detection Crucial
Prostate cancer, a common disease in men, is often diagnosed late, as exemplified by former US President Biden's recent advanced-stage diagnosis; risk factors include age, ethnicity, and family history, with rates sharply rising after age 50.
Progress
40% Bias Score
Rising Prostate Cancer Cases Highlight Need for Early Detection
Prostate cancer, affecting one in eight men, is highly curable if detected early; however, rising cases and delayed diagnoses due to mild symptoms and screening guideline confusion result in reduced survival rates, as exemplified by President Biden's late-stage diagnosis.
Rising Prostate Cancer Cases Highlight Need for Early Detection
Prostate cancer, affecting one in eight men, is highly curable if detected early; however, rising cases and delayed diagnoses due to mild symptoms and screening guideline confusion result in reduced survival rates, as exemplified by President Biden's late-stage diagnosis.
Progress
40% Bias Score
Statins Linked to 40% Increased Sepsis Survival Rate
A major trial of 12,000 sepsis patients in Israel found that those taking statins had a 39% lower risk of death compared to those not taking statins, highlighting the potential of this medication to significantly reduce sepsis mortality.
Statins Linked to 40% Increased Sepsis Survival Rate
A major trial of 12,000 sepsis patients in Israel found that those taking statins had a 39% lower risk of death compared to those not taking statins, highlighting the potential of this medication to significantly reduce sepsis mortality.
Progress
40% Bias Score
FDA Clears New Blood Test for Alzheimer's Diagnosis
The FDA approved the Lumipulse G Plasma Ratio blood test for Alzheimer's, offering a less invasive and potentially cheaper diagnostic for patients over 55 with cognitive decline; the test achieved 92% accuracy in clinical trials detecting amyloid and tau proteins.
FDA Clears New Blood Test for Alzheimer's Diagnosis
The FDA approved the Lumipulse G Plasma Ratio blood test for Alzheimer's, offering a less invasive and potentially cheaper diagnostic for patients over 55 with cognitive decline; the test achieved 92% accuracy in clinical trials detecting amyloid and tau proteins.
Progress
44% Bias Score
Australian Comedian Magda Szubanski Diagnosed with Stage Four Blood Cancer
Australian comedian Magda Szubanski, 64, was diagnosed with stage four Mantle Cell Lymphoma (MCL), a rare and aggressive blood cancer, and is undergoing the intensive "Nordic protocol" treatment, which involves chemotherapy and immunotherapy.
Australian Comedian Magda Szubanski Diagnosed with Stage Four Blood Cancer
Australian comedian Magda Szubanski, 64, was diagnosed with stage four Mantle Cell Lymphoma (MCL), a rare and aggressive blood cancer, and is undergoing the intensive "Nordic protocol" treatment, which involves chemotherapy and immunotherapy.
Progress
24% Bias Score
Chemical Castration Trial Shows Promise, But Ethical Concerns Remain
A Stockholm trial showed degarelix reduced child sexual abuse risk in 52 men within two weeks, but the limited evidence and ethical concerns around mandatory chemical castration, currently employed in the US and some European countries, remain.
Chemical Castration Trial Shows Promise, But Ethical Concerns Remain
A Stockholm trial showed degarelix reduced child sexual abuse risk in 52 men within two weeks, but the limited evidence and ethical concerns around mandatory chemical castration, currently employed in the US and some European countries, remain.
Progress
52% Bias Score
30 DNA Regions Linked to Obsessive-Compulsive Disorder Risk
An international study identified 30 DNA regions linked to obsessive-compulsive disorder (OCD) risk, analyzing 53,660 cases and over 2 million controls, revealing 249 associated genes (25 strongly linked); future research will focus on diverse populations and developing new treatments.
30 DNA Regions Linked to Obsessive-Compulsive Disorder Risk
An international study identified 30 DNA regions linked to obsessive-compulsive disorder (OCD) risk, analyzing 53,660 cases and over 2 million controls, revealing 249 associated genes (25 strongly linked); future research will focus on diverse populations and developing new treatments.
Progress
24% Bias Score
Biden's Advanced Prostate Cancer Diagnosis Spurs Global Concern
Former President Joe Biden has been diagnosed with stage five prostate cancer that has spread to his bones, prompting global concern and highlighting the importance of early detection for this common but treatable disease.
Biden's Advanced Prostate Cancer Diagnosis Spurs Global Concern
Former President Joe Biden has been diagnosed with stage five prostate cancer that has spread to his bones, prompting global concern and highlighting the importance of early detection for this common but treatable disease.
Progress
40% Bias Score
Showing 1 to 12 of 120 results